NORMOSANG 25 mg/ml, concentrate for solution for infusion 4 ampoules of 10 ml
Active ingredients: Haemin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion4 ampoules of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NORMOSANG 25 mg/ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 4 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- RECORDATI RARE DISEASES
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1996
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65109937CIP75586111CIP133400955861119Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HÉMINEsolution | 250 mg · 10 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.